Quality of antiepileptic drugs in sub-Saharan Africa: A study in Gabon, Kenya, and Madagascar

Archive ouverte

Jost, Jérémy | Ratsimbazafy, Voa | Nguyen, Thu Trang | Nguyen, Thuy Linh | Dufat, Hanh | Dugay, Annabelle | Ba, Alassane | Sivadier, Guilhem | Mafilaza, Yattussia | Jousse, Cyril, C. | Traïkia, Mounir | Leremboure, Martin | Auditeau, Emilie | Raharivelo, Adeline | Ngoungou, Edgard Brice | Kariuki, Symon m. | Newton, Charles | Preux, Pierre-Marie

Edité par CCSD ; Wiley -

International audience. ObjectiveEpilepsy is a major public health issue in low‐ and middle‐income countries, where the availability and accessibility of quality treatment remain important issues, the severity of which may be aggravated by poor quality antiepileptic drugs (AEDs). The primary objective of this study was to measure the quality of AEDs in rural and urban areas in 3 African countries. MethodsThis cross‐sectional study was carried out in Gabon, Kenya, and Madagascar. Both official and unofficial supply chains in urban and rural areas were investigated. Samples of oral AEDs were collected in areas where a patient could buy or obtain them. Pharmacological analytical procedures and Medicine Quality Assessment Reporting Guidelines were used to assess quality. ResultsIn total, 102 batches, representing 3782 units of AEDs, were sampled. Overall, 32.3% of the tablets were of poor quality, but no significant difference was observed across sites: 26.5% in Gabon, 37.0% in Kenya, and 34.1% in Madagascar (P = .7). The highest proportions of substandard medications were found in the carbamazepine (38.7%; 95% confidence interval [CI] 21.8‐57.8) and phenytoin (83.3%; 95% CI 35.8‐99.5) batches, which were mainly flawed by their failure to dissolve. Sodium valproate was the AED with the poorest quality (32.1%; 95% CI 15.8‐42.3). The phenobarbital (94.1%; 95% CI 80.3‐99.2) and diazepam (100.0%) batches were of better quality. The prevalence of substandard quality medications increased in samples supplied by public facilities (odds ratio [OR] 9.9; 95% CI 1.2‐84.1; P < .04) and manufacturers located in China (OR 119.8; 95% CI 8.7‐1651.9; P < .001). The prevalence of AEDs of bad quality increased when they were stored improperly (OR 5.4; 95% CI 1.2‐24.1; P < .03). SignificanceNo counterfeiting was observed. However, inadequate AED storage conditions are likely to lead to ineffective and possibly dangerous AEDs, even when good‐quality AEDs are initially imported.

Suggestions

Du même auteur

Availability and cost of major and first-line antiepileptic drugs: a comprehensive evaluation in the capital of Madagascar

Archive ouverte | Jost, Jérémy | CCSD

International audience. Background: The prevalence of epilepsy is high in Madagascar (23.5/1000), as is the treatment gap (estimated at 92 %). The health system of the country is underfunded; some AEDs are used, a...

Herbal medicine for epilepsy seizures in Asia, Africa and Latin America: A systematic review

Archive ouverte | Auditeau, Emilie | CCSD

International audience. RELEVANCE:More than 70 million people suffer epilepsy worldwide. Low availability of anti-epileptic drugs, side-effects and drug-resistant epilepsy affect the quality of life of persons with ...

Use of herbal medicines in rural communities in the northern coast of Peru and in rural and urban communities of Laos to treat people with epilepsy

Archive ouverte | Auditeau, Emilie | CCSD

International audience. Background: More than 70 million people suffer epilepsy worldwide. Low availability of anti-epileptic drugs, side-effects and drug-resistant epilepsy affect the quality of life of persons wit...

Chargement des enrichissements...